Dr.Mayson是以临床质量为核心的医疗AI能辅助诊疗，拥有深度学习、自然语言处理AI前沿技术，融合了国内权威指南的医学知识库，广泛应用于大型三甲医院及基层医疗机构，无缝嵌入电子病历评级，为医疗管理与临床决策提供全面、智能、高效的辅助诊疗支持。
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | Qiming Ven... | qimingvent... |
| - | Qiming Ven... | qimingvc.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.09.2019 | - | $30M | - |
Mentions in press and media 3
| Date | Title | Description |
| 03.09.2019 | China Digest: Qiming invests $30m in Huimei; AutoX to deploy robo-taxis in Shanghai | Premium Qiming has invested $30m in Huimei Technology, a Chinese medical AI solutions player, while AutoX and Shanghai authorities have announced a partnership to pilot the real-world use case of the country’s driverless future. Continue re... |
| - | Huimei Closes $30 Million Round for AI-based Hospital Clinical Decision Support | - |
| - | Huimei Technology | “Medical Artificial Intelligence solutions are the core application of Dr.Mayson is a medical AI intelligent diagnostic tool with high quality as the core, its core products include High quality Medical Support System (CDSS), single disease... |